Altered expression of tyrosine hydroxylase in the locus coeruleus noradrenergic system in citalopram neonatally exposed rats and monoamine oxidase A knock out mice

Anatomical Record

Volumn 294, Issue 10, 2011, Pages 1685-1697

  Zhang, Junlin ^a   Darling, Ryan D ^a   Paul, Ian A ^b   Simpson, Kimberly L ^a,b   Chen, Kevin ^c   Shih, Jean C ^c   Lin, Rick C S ^a,b  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Antidepressants; Knock out mice; Monoamine oxidase; Neonates; Norepinephrine; Tyrosine hydroxylase

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; CITALOPRAM; DOPAMINE BETA MONOOXYGENASE; NORADRENALIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENDRITE; DRUG ACTIVITY; ENVIRONMENTAL FACTOR; HEREDITY; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LOCUS CERULEUS; MOUSE; NEOCORTEX; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANIMALS, NEWBORN; CITALOPRAM; DOPAMINE BETA-HYDROXYLASE; FEMALE; IMMUNOENZYME TECHNIQUES; LOCUS COERULEUS; MICE; MICE, KNOCKOUT; MONOAMINE OXIDASE; NEURONS; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; RATS; RATS, LONG-EVANS; SEROTONIN UPTAKE INHIBITORS; TYROSINE 3-MONOOXYGENASE;

MUS; RATTUS; RODENTIA;

EID: 80052995331     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.21350     Document Type: Article

References (55)

1. Ansorge MS, Morelli E, Gingrich JA. 2008. Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviors in mice. J Neurosci 28: 199-207.
2. Ansorge MS, Zhou M, Lira A, Hen R, Gingrich JA. 2004. Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 306: 879-881.
3. Asmus SE, Anderson EK, Ball MW, Barnes BA, Bohnen AM, Brown AM, Hartley LJ, Lally MC, Lundblad TM, Martin JB, Moss BD, Phelps KD, Phillips LR, Quilligan CG, Steed RB, Terrell SL, Warner AE. 2008. Neurochemical characterization of tyrosine hydroxylase-immunoreactive interneurons in the developing rat cerebral cortex. Brain Res 1222: 95-105.
4. Booze RM, Hall JA, Cress NM, Miller GD, Davis JN. 1988. DSP-4 treatment produces abnormal tyrosine hydroxylase immunoreactive fibers in rat hippocampus. Exp Neurol 101: 75-86.
5. Bortolato M, Chen K, Shih J. 2008. Monoamine oxidase inactivation: from pathophysiology to therapeutics. Adv Drug Deliv Rev 60: 1527-1533.
6. Butler SG, Meegan MJ. 2008. Recent developments in the design of anti-depressive therapies: targeting the serotonin transporter. Curr Med Chem 15: 1737-1761.
7. Cases O, Seif I, Grimsby J, Caspar P, Chen K, Pournin S, Muller U, Aguet M, Babinet C, Shih JC, Maeyer ED. 1995. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science 268: 1763-1766.
8. Chang MS, Sved AF, Zigmond MJ, Austin MC. 2000. Increased transcription of the tyrosine hydroxylase gene in individual locus coeruleus neurons following footshock stress. Neuroscience 101: 131-139.
9. Descarries L, Lemay B, Doucet G, Berger B. 1987. Regional and laminar density of the dopamine innervation in adult rat cerebral cortex. Neuroscience 21: 807-824.
10. Devau G, Multon MF, Pujol JF, Buda M. 1987. Inhibition of tyrosine hydroxylase activity by serotonin in explants of newborn rat locus ceruleus. J Neurochem 49: 665-670.
11. Dreyer J, Schleicher M, Tappe A, Schilling K, Kuner T, Kusumawidijaja G, Müller-Esterl W, Oess S, Kuner R. 2004. Nitric oxide synthase (NOS)-interacting protein interacts with neuronal NOS and regulates its distribution and activity. J Neurosci 24: 10454-10465.
12. Falck B, Hillarp NA, Thieme G, Torp A. 1962. Fluorescence of catecholamines and releated compounds condensed with formaldehyde. J Histochem Cytochem 10: 348-354.
13. Feuerstein TJ, Hertting G, Lupp A, Neufang B. 1986. False labelling of dopaminergic terminals in the rabbit caudate nucleus: uptake and release of [3H]-5-hydroxytryptamine. Br J Pharmacol 88: 677-684.
14. Fuxe K, Hamburger B, Hokfelt T. 1968. Distribution of noradrenaline nerve terminals in cortical areas of the rat. Brain Res 8: 125-131.
15. Haddjeri N, Claude de Montigny, Pierre Blier. 1997. Modulation of the firing activity of noradrenergic neurons in the rat locus coeruleus by the 5-hydroxytrptamine system. Br J Pharmacol 120: 865-875.
16. Harley CW. 2003. Norepinephrine and serotonin axonal dynamics and clinical depression: a commentary on the interaction between serotonergic and noradrenergic axons during axonal regeneration. Exp Neurol 184: 24-26.
17. Hartman BK, Zide D, Udenfriend S. 1972. The use of dopamine β-hydroxylase as a marker for the central noradrenergic nervous system in rat brain. Proc Nat Acad Sci USA 69: 2722-2726.
18. Hokfelt T, Johansson O, Fuxe K, Goldstein M, Park D. 1976. Immunohistochemical studies on the localization and distribution of monoamine neuron systems in the rat brain. I. Tyrosine hydroxylase in the mes- and diencephalon. Med Biol 54: 427-453.
19. Hokfelt T, Johansson O, Fuxe K, Goldstein M, Park D. 1977. Immunohistochemical studies on the localization and distribution of monoamine neuron systems in the rat brain II. Tyrosine hydroxylase in the telencephalon. Med Biol 55: 21-40.
20. Kitayama I, Nakamura S, Yaga T, Murase S, Nomura J, Kayahara T, Nakano K. 1994. Degeneration of locus coeruleus axons in stress-induced depression model. Brain Res Bull 35: 573-580.
21. Kitayama I, Yaga T, Kayahara T, Nakano K, Murase S, Otani M, Nomura J. 1997. Long-term stress degenerates, but imipramine regenerates, noradrenergic axons in the rat cerebral cortex. Biol Psychiatry 42: 687-696.
22. Levitt P. 1988. Normal pharmacological and morphometric parameters in the noradrenergic hyperinnervated mutant mouse, "tottering." Cell Tissue Res 252: 175-180.
23. Levitt P, Moore RY. 1979. Development of the noradrenergic innervation of neocortex. Brain Res 162: 243-259.
24. Levitt P, Noebels JL. 1981. Mutant mouse tottering: selective increase of locus coeruleus axons in a defined single-locus mutation. Proc Natl Acad Sci USA 78: 4630-4634.
25. Lewis BD, Renaud B, Buda M, Pujol JF. 1976. Time-course variations in tyrosine hydroxylase activity in the rat locus coeruleus after electrolytic destruction of the nuclei raphe dorsalis or raphe centralis. Brain Res 108: 339-349.
26. Lewis DA, Campbell MJ, Foote SL, Goldstein M, Morrison JH. 1987. The distribution of tyrosine hydroxylase-immunoreactive fibers in primate neocortex is widespread but regionally specific. J Neurosci 7: 279-290.
27. Lin RCS, Matesic DF, Connor JA. 1997. The role of dendritic dysfunction in neurodegeneration. Ann N Y Acad Sci 825: 134-145.
28. Liu Y, Ishida Y, Shinoda K, Nakamura S. 2003. Effects of repeated stress on regeneration of serotonergic and noradrenergic axons in the cerebral cortex of adult rats. Neurosci Lett 339: 227-230.
29. Maciag D, Simpson KL, Coppinger D, Lu Y, Wang Y, Lin RCS, Paul IA. 2006. Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry. Neuropsychopharmacology 31: 47-57.
30. Mason ST, Fibiger HC. 1979. Current concepts. I. Anxiety: the locus coeruleus disconnection. Life Sci 25: 2141-2147.
31. McRae-Degueurce A, Berod A, Mermet A, Keller A, Chouvet G, Joh TH, Pujol JF. 1982. Alterations in tyrosine hydroxylase activity elicited by raphe nuclei lesions in the rat locus coeruleus: evidence for the involvement of serotonin afferents. Brain Res 235: 285-301.
32. Nakamura S. 1990. Antidepressants induce regeneration of catecholaminergic axon terminals in the rat cerebral cortex. Neurosci Lett 111: 64-68.
33. Nakamura S. 1991. Axonal sprouting of noradrenergic locus coeruleus neurons following repeated stress and antidepressant treatment. In: Barnes CD, Pompeiano O, editors. Neurobiology of the locus coeruleus: progress in brain research. Amsterdam: Elsevier Science Publishers B.V. p 587-598.
34. Nakamura S, Sakaguchi T, Aoki F. 1989. Electrophysiological evidence for terminal sprouting of locus coeruleus neurons following repeated mild stress. Neurosci Lett 100: 147-152.
35. Nestler EJ, Alreja M, Aghajanian GK. 1999. Molecular control of locus coeruleus neurotransmission. Soc Biol Psychiatry 46: 1131-1139.
36. Nestler EJ, Mcmahon A, Sabban EL, Tallman JF, Duman RS. 1990. Chronic antidepressant administration decreases the expression of tyrosine hydroxylase in the rat locus coeruleus. Proc Natl Acad Sci USA 87: 7522-7526.
37. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinates. 2nd ed. Sydney: Academic press.
38. Pickel VM, Joh TH, Reis DJ. 1975. Ultrastructural localization of tyrosine hydroxylase in noradrenergic neurons of brain. Proc Nat Acad Sci USA 72: 659-663.
39. Redmond DE Jr, Huang YH. 1979. Current concepts. II. New evidence for a locus coeruleus-norepinephrine connection with anxiety. Life Sci 25: 2149-2162.
40. Richard F, Faucon-Biguet N, Labatut R, Rollet D, Mallet J, Buda M. 1988. Modulation of tyrosine hydroxylase gene expression in rat brain and adrenals by exposure to cold. J Neurosci Res 20: 32-37.
41. Sabban EL, Kvetnanský R. 2001. Stress-triggered activation of gene expression in catecholaminergic systems: dynamics of transcriptional events. Trends Neurosci 24: 91-98.
42. Sakaguchi T, Nakamura S. 1990. Duration-dependent effects of repeated restraint stress on cortical projections of locus coeruleus neurons. Neurosci Lett 118: 193-196.
43. Satoh J, Suzuki K. 1990. Tyrosine hydroxylase-immunoreactive neurons in the mouse cerebral cortex during the postnatal period. Dev Brain Res 53: 1-5.
44. Scott AL, Bortolato M, Chen K, Shih JC. 2008. Novel monoamine oxidase A knock out mice with human-like spontaneous mutation. Mol Neurosci 19: 739-743.
45. Serova LI, Nankova BB, Feng Z, Hong JS, Hutt M, Sabban EL. 1999. Heightened transcription for enzymes involved in norepinephrine biosynthesis in the rat locus coeruleus by immobilization stress. Biol Psychiatry 45: 853-862.
46. Shih JC, Chen K, Ridd M. 1999. Monoamine oxidases: from genes to behavior. Ann Rev Neurosci 22: 197-217.
47. Simpson KL, Lin RCS. 2002. Cellular and molecular mechanisms of ischemic tolerance. In: Lin RCS, editor. New concepts in cerebral ischemia. Boca Raton: CRC Press. p 263-306.
48. Simpson KL, Lin RCS. 2008. Neuroanatomical and chemical orgaization of the locus coeruleus. In: Ordway GA, Schwartz MA, Frazer A, editors. Brain norepinephrine: neurobiology and therapeutics. New York: Cambridge University Press. p 9-52.
49. Sturtz F, Rollet D, Faucon Biguet N, Mallet J, Buda M. 1994. Long-term alteration in rat tyrosine hydroxylase mRNA levels in locus coeruleus after intraventricular injection of 5, 6-dihydroxytrptamine. Brain Res Mol Brain Res 22: 107-112.
50. Vizi ES, Zsilla G, Caron MG, Kiss JP. 2004. Uptake and release of norepinephrine by serotonergic terminals in norepinephrine transporter knock-out mice: implications for the action of selective serotonin reuptake inhibitors. J Neurosci 24: 7888-7894.
51. Watanabe Y, McKittrick CR, Blanchard DC, Blanchard RJ, McEwen BS, Sakai RR. 1995. Effects of chronic social stress on tyrosine hydroxylase mRNA and protein levels. Brain Res Mol Brain Res 32: 176-180.
52. Weaver KJ, Paul IA, Lin RCS, Simpson KL. 2010. Neonatal exposure to citalopram selectively alters the expression of the serotonin transporter in the hippocampus: dose-dependent effects. Anat Rec 293: 1920-1932.
53. Weiss JM, Boss-Williams KA, Moore JP, Demetrikopoulos MK, Ritchie JC, West CHK. 2005. Testing the hypothesis that locus coeruleus hyperactivity produces depression-related changes via galanin. Neuropeptides 39: 281-287.
54. Zhang J, Ryan DD, Thaggard DD, Paul IA, Simpson KL, Lin RCS. 2009. Neonatal exposure to antidepressants alters developing serotonin and dopamine systems in rats. Program No. 436.14. 2009 Neuroscience Meeting Planner. Chicago, IL; Society for Neuroscience, 2009. Online.
55. Zhou FM, Liang Y, Salas R, Zhang L, De Biasi M, Dani JA. 2005. Corelease of dopamine and serotonin from striatal dopamine terminals. Neuron 46: 65-74.